Hyug-Gi Kim1, Chan-Hee Lee1, Chang-Woo Ryu2, Soonchan Park2, Hak Young Rhee3, Kyung Mi Lee4, Wook Jin2, Dal-Mo Yang2, Soo Yeol Lee1, Tian Liu5, Yi Wang5, and Geon-Ho Jahng2
1Biomedical Engineering, Kyung Hee University, Gyeonggi-do, Korea, Republic of, 2Radiology, Kyung Hee University Hospital at Gangdong, Seoul, Korea, Republic of, 3Neurology, Kyung Hee University Hospital at Gangdong, Seoul, Korea, Republic of, 4Radiology, Kyung Hee University Hospital, Seoul, Korea, Republic of, 5Biomedical Engineering and Radiology, Cornell University, New York, NY, United States
Synopsis
One of the important characteristics of Alzheimer’s disease (AD) is the
iron accumulations in the brain. To estimate the
quantitative susceptibility effects in AD brain, the susceptibility changes
were investigated in subjects with 19 cognitive normal (CN), 19 mild cognitive
impairment (MCI) and 19 AD. Seven-echo 3D gradient-echo images were obtained to
map quantitative susceptibility mapping (QSM) and 3D T1-weighted images using
the MPRAGE sequence were also obtained to map gray matter volume (GMV). Both
voxel-based and ROI-based analyses were performed to evaluate the group
differences. The result showed that QSM can be useful to evaluate the
AD brain.Purpose
One of the important characteristics of Alzheimer’s disease(AD) is the
iron accumulations in the brain
1.A quantitative susceptibility map(QSM) technique can be used to quantify
the iron contents. Therefore, QSM may be useful to evaluate the AD brain. The objective of this
study, therefore, was to systematically investigate the brain changes in the subjects
with cognitive normal(CN), mild cognitive impairment(MCI) and AD by using both
voxel-by-voxel based and ROI-based analysis for both QSM and gray matter volume(GMV) data.
Materials and Methods
Nineteen CN(mean age = 65.74, 14 females and 5 males), 19 MCI(mean age
= 71.84, 14 females and 5 males), and 19 AD subjects(mean age = 72.84, 17
females and 2 males) were participated after informed consent. For the QSM data, a 3D gradient-echo(FFE) sequence was run with seven echoes(first TE/△TE/final TE=3.4/5.9/39 ms). For an image registration, for generating anatomical
templates, and for evaluating GMV, sagittal
structural 3D T1-weighted(3DT1W) images were acquired with the
magnetization-prepared rapid acquisition of gradient echo (MPRAGE) sequence(1mm isotropic voxel). QSM data were
obtained with the morphology enabled dipole inversion (MEDI) software
2.
For the QSM data, the susceptibility value in each voxel was subtracted by the
reference values which were estimated by the average of the susceptibility
values in the bilateral posterior ventricular region for each subject. The Diffeomorphic
Anatomical Registration Through Exponentiated Lie Algebra(DARTEL) toolbox and Statistical
Parametric Mapping Version 8(SPM8) were used to post-processing. A voxel-based
statistical group analysis was performed for QSM data and GMV using a one-way
analysis of variance(ANOVA) test with the gender and age as covariates. ROIs(eight well-known iron accumulation regions; hippocampus, amygdala, globus pallibus,
precuneu, pulvinar, putamen, red nucleus and thalamus
3/ five
well-known amyloid β accumulation regions; neocortex, allocortex,
entorhinal cortex, anterior cingulate cortex and posterior cingulate cortex
4)-based
statistical group analysis was also performed for QSM data and GMV. Finally, the receiver operating characteristic(ROC)
curve analysis was performed to demonstrate sensitivity and specificity of GMVs
and QSM to differentiate among the subject groups for each ROI.
Results
Fig.1 demonstrates the
differences of voxel-based statistical analysis of GMV (A) and QSM (B) values
between the CN and AD groups as well as the mean values of percentage changes
of GMV (C) and QSM (D) using ROIs-based statistical analysis on the MCI and AD
against the CN group. For the voxel-based analyses, decreased GMV in AD compared with CN was
found at some areas, but no differences between other groups. Increased QSM values in AD compared with CN were found several brain areas, included in the
right parahippocampal gyrus, but no differences between other groups. For the ROI-based analyses, GMV was decreased in
MCI and AD at several areas compared to the CN group. However, GMV was increased in the MCI and AD
groups at pulvinar, red nucleus, thalamus and allocortex regions compared to
the CN group. QSM values were increased in the MCI and AD groups compared to the CN group for all
ROIs. Results of ROC curves analysis showed that QSM values were significantly differentiated among
the three groups. QSM values were
differentiated between CN and MCI groups in the in the neocortex(AUC=0.722, p=0.0091), allocortex(AUC=0.772,
p=0.0005), entorhinal cortex(AUC=0.681, p=0.0453), anterior cingulate cortex(AUC=0.739, p=0.0037), posterior cingulate cortex(AUC=0.742, p=0.0033)
regions. However, GMV values were only differentiated between CN and MCI/AD
group as well as between MCI and AD, but not differentiated between CN and MCI groups.
Discussions
Quantification of iron concentrations in vivo is
instrumental for understanding the role of irons in many neurological diseases.
From the comparison between the QSM values and GMVs, we found higher
sensitivity of QSM data than GMV data.
For the QSM data, the susceptibility values increased in
eight iron accumulation and five amyloid β accumulation regions from CN to MCI and to AD. Iron is a
paramagnetic substance and contributes to dephasing of the signals so AD is
expected to have the most iron plaques
5. In particular, the QSM
values are more effective to evaluate in the precuneus and neocortex regions
than the GMVs between the CN and MCI groups. The QSM technique offers more
efficiency information of the susceptibility effects for early diagnosis for AD
than the GMV estimation.
Conclusion
The susceptibility
effects of the QSM data in the precuneus and neocortex region was attribute to
the iron accumulation in patients. The QSM data proved to be more effective to
evaluate the early stage for AD than GMVs. Therefore, the susceptibility
effects in the QSM can be used to an early diagnosis for AD. Furthermore, the
QSM technique can be used as an imaging biomarker to evaluate AD.
Acknowledgements
This research was supported by the National Research Foundation of Korea(NRF) grant funded
by the Korea government(MSIP)(2014R1A2A2A01002728).
References
1.Dedman DJ,
Treffry A, Candy JM et al, Biochem J, 1992 Oct 15;287 ( Pt 2):509-14. 2.Liu T,
Wang Y et al, Magn Reson Med, 2011 Sep;66(3):777-83. 3. Haacke EM, Cheng NY,
Obenaus A et al, Magn Reson Imaging. 2005 Jan;23(1):1-25. 4.Vandeberghe R,
Chetelat G et al, Neuroimage Clin. 2013 Apr 6;2:497-511. 5.Langkammer C,
Schweser F, Reichenbach JR et al, Neuroimage. 2012 Sep;62(3):1593-9.